# Willow Birch Pharma, Inc. – FDA Inspection, May 3, 2024

Source: https://www.keypedia.com/records/fda_inspections/willow-birch-pharma-inc/7833347e-3e34-4dd1-93ac-54c266b61f27
Source feed: FDA_Inspections

> FDA inspection 1237719 of Willow Birch Pharma, Inc., May 03, 2024. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 211. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1237719
- Company Name: Willow Birch Pharma, Inc.
- Inspection Date: 2024-05-03
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 1

## Related Documents

- [FDA Inspection 991592 - 2016-10-28](https://www.keypedia.com/records/fda_inspections/willow-birch-pharma-inc/d5450bf7-e3bc-40c3-a336-d78b3a18e1db)

## Related Officers

- [Investigator](https://www.keypedia.com/people/demario-l-walls/c69c4c87-f001-45ab-8d7b-b45c60226ff1)
- [FDA Associated Person](https://www.keypedia.com/people/megan-t-ziegler/3e83a317-701a-4e40-bb43-34d294d3448f)

Company: https://www.keypedia.com/companies/willow-birch-pharma-inc/a2496c28-dd6d-42f2-b524-6f6b8c20dbb8

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
